跳至主要内容
临床试验/ACTRN12622000517774
ACTRN12622000517774尚未招募未知

Evaluation of the effects of supplementation with Pycnogenol (French Pinus pinaster bark extract) on exercise performance in a population of cyclists: A double blind crossover trial.

a Trobe University0 个研究点目标入组 20 人开始时间: 2022年3月31日最近更新:

试验速览

阶段
未知
状态
尚未招募
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 45 Years(—)
性别
All

入选标准

  • 1. Adults between the ages of 18-45
  • 2. Actively participate in cycling (minimum 3 sessions per week)
  • 3. competitive C grade rider or higher, completing approximately 200 km or more per week

排除标准

  • 1) Are pregnant and/or breastfeeding.
  • 2) Present with a history of treatment for metabolic disease (e.g., diabetes or cardiovascular disease).
  • 3) Are currently using any prescription medication which could impact on inflammatory pathways (e.g., Warfarin, aspirin, ibuprofen [nurofen]).
  • 4) Have any medical contraindications to exercise.
  • 5) Are currently injured.

研究者

发起方
a Trobe University

相似试验

Investigating the effect of French bark extract,... | 临床试验